ARCHIVES

NCI Splits Prevention and control Division; Rimer to Direct Division Of Cancer Conrol

This article is from The Cancer Letter archive.

Vol. 23 No. 29 | July 25, 1997

Download PDF Visit The Full Archive

Related Articles

Business & Regulatory Report March edition (8 pages) included.

March 19, 2004

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

MD Anderson Survey Shows Faculty Dissatisfaction with Top Leaders

May 23, 2014

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

September 19, 1975

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

April 4, 1986